With all the waiting I’ve done at the hemeonc clinic the past 2 years you’d think they’d at least offer me a complimentary bottle of chemo
January 7, 2026 at 10:09 PM
With all the waiting I’ve done at the hemeonc clinic the past 2 years you’d think they’d at least offer me a complimentary bottle of chemo
We are excited to share new additions to the HemeHub platform, including hybrid events that translate emerging evidence into clinical practice.
👉 Explore our hybrid events and the 2026 symposium:
hemehub.org/hybrid-events
#Hematology #HemeHub #HybridEvents #ClinicalUpdates #PatientCare #HemeOnc
👉 Explore our hybrid events and the 2026 symposium:
hemehub.org/hybrid-events
#Hematology #HemeHub #HybridEvents #ClinicalUpdates #PatientCare #HemeOnc
December 30, 2025 at 2:45 AM
We are excited to share new additions to the HemeHub platform, including hybrid events that translate emerging evidence into clinical practice.
👉 Explore our hybrid events and the 2026 symposium:
hemehub.org/hybrid-events
#Hematology #HemeHub #HybridEvents #ClinicalUpdates #PatientCare #HemeOnc
👉 Explore our hybrid events and the 2026 symposium:
hemehub.org/hybrid-events
#Hematology #HemeHub #HybridEvents #ClinicalUpdates #PatientCare #HemeOnc
📢 Rush University Medical Center is #hiring a Clinical Pharmacy Specialist HemeOnc at Rush University Medical Center!
📍 Illinois, United States
#jobalert #jobsearch
🔗 http://jbs.ink/SEhrC5m17LYD
#design
📍 Illinois, United States
#jobalert #jobsearch
🔗 http://jbs.ink/SEhrC5m17LYD
#design
December 27, 2025 at 1:24 AM
📢 Rush University Medical Center is #hiring a Clinical Pharmacy Specialist HemeOnc at Rush University Medical Center!
📍 Illinois, United States
#jobalert #jobsearch
🔗 http://jbs.ink/SEhrC5m17LYD
#design
📍 Illinois, United States
#jobalert #jobsearch
🔗 http://jbs.ink/SEhrC5m17LYD
#design
📢 Rush University Medical Center is #hiring a Clinical Pharmacy Specialist HemeOnc at Rush University Medical Center!
📍 Illinois, United States
#jobalert #jobsearch
🔗 http://jbs.ink/SEhrC5m17LYD
#design
📍 Illinois, United States
#jobalert #jobsearch
🔗 http://jbs.ink/SEhrC5m17LYD
#design
December 27, 2025 at 1:24 AM
📢 Rush University Medical Center is #hiring a Clinical Pharmacy Specialist HemeOnc at Rush University Medical Center!
📍 Illinois, United States
#jobalert #jobsearch
🔗 http://jbs.ink/SEhrC5m17LYD
#design
📍 Illinois, United States
#jobalert #jobsearch
🔗 http://jbs.ink/SEhrC5m17LYD
#design
📢 Rush University Medical Center is #hiring a Clinical Pharmacy Specialist HemeOnc at Rush University Medical Center!
📍 Illinois, United States
#jobalert #jobsearch
🔗 http://jbs.ink/SEhrC5m17LYD
#design
📍 Illinois, United States
#jobalert #jobsearch
🔗 http://jbs.ink/SEhrC5m17LYD
#design
December 27, 2025 at 1:14 AM
📢 Rush University Medical Center is #hiring a Clinical Pharmacy Specialist HemeOnc at Rush University Medical Center!
📍 Illinois, United States
#jobalert #jobsearch
🔗 http://jbs.ink/SEhrC5m17LYD
#design
📍 Illinois, United States
#jobalert #jobsearch
🔗 http://jbs.ink/SEhrC5m17LYD
#design
🩸This study shows that hematopoietic cell transplantation is curative for >150 inborn errors of immunity. In Wiskott–Aldrich syndrome, early transplant achieves ~91% 5-year survival, especially with robust donor myeloid chimerism.
doi.org/10.46765/267...
#HSCT #HemeOnc #HemeSky #MedSky #JBMTCT
doi.org/10.46765/267...
#HSCT #HemeOnc #HemeSky #MedSky #JBMTCT
December 24, 2025 at 1:20 PM
This study demonstrates that alterations in the RAS-MAPK pathway guide prognosis & treatment. PTPN11 & NF1 cases require early allogeneic HCT, the only curative option, while KRAS/NRAS allow individualized management.
Access the full free article at doi.org/10.46765/267...
#HemeOnc #HemeSky #MedSky
Access the full free article at doi.org/10.46765/267...
#HemeOnc #HemeSky #MedSky
December 22, 2025 at 2:15 PM
This study demonstrates that alterations in the RAS-MAPK pathway guide prognosis & treatment. PTPN11 & NF1 cases require early allogeneic HCT, the only curative option, while KRAS/NRAS allow individualized management.
Access the full free article at doi.org/10.46765/267...
#HemeOnc #HemeSky #MedSky
Access the full free article at doi.org/10.46765/267...
#HemeOnc #HemeSky #MedSky
Discover expert perspectives through HemeHub webinars and past sessions, available directly on our website and on YouTube.
🔗Visit hemehub.org today to learn more!
#HemeHub #Hematology #HemeEd #MedEd #HemeOnc
🔗Visit hemehub.org today to learn more!
#HemeHub #Hematology #HemeEd #MedEd #HemeOnc
Catch up on HemeHub webinars anytime!
Watch webinars and past sessions anytime on our website — all organized by topic for easy navigation.
🔗Visit hemehub.org today!
#HemeHub #Hematology #HemeEd #MedEd #MedicalEducation #OnlineLearning #HemeCommunity
Watch webinars and past sessions anytime on our website — all organized by topic for easy navigation.
🔗Visit hemehub.org today!
#HemeHub #Hematology #HemeEd #MedEd #MedicalEducation #OnlineLearning #HemeCommunity
December 20, 2025 at 11:47 PM
Discover expert perspectives through HemeHub webinars and past sessions, available directly on our website and on YouTube.
🔗Visit hemehub.org today to learn more!
#HemeHub #Hematology #HemeEd #MedEd #HemeOnc
🔗Visit hemehub.org today to learn more!
#HemeHub #Hematology #HemeEd #MedEd #HemeOnc
Long-read sequencing is reshaping diagnostics in hematologic malignancies. With reads tens of thousands of bases long, it can reveal structural variants, fusions, and methylation changes more quickly and comprehensively for leukemia care. https://ow.ly/A9R450XJKum
#HemeOnc #HemeSky #MedSky
#HemeOnc #HemeSky #MedSky
December 17, 2025 at 1:01 PM
Long-read sequencing is reshaping diagnostics in hematologic malignancies. With reads tens of thousands of bases long, it can reveal structural variants, fusions, and methylation changes more quickly and comprehensively for leukemia care. https://ow.ly/A9R450XJKum
#HemeOnc #HemeSky #MedSky
#HemeOnc #HemeSky #MedSky
Don’t forget to claim your CME/MOC credit for attending #ASH25! ✅ Complete the evaluation survey by April 10, 2026, to claim credit and print your certificate. Claim now: https://ow.ly/HGGO50XKxJy
#HemeSky #MedSky #Hematology #HemeOnc
#HemeSky #MedSky #Hematology #HemeOnc
December 16, 2025 at 7:55 PM
Don’t forget to claim your CME/MOC credit for attending #ASH25! ✅ Complete the evaluation survey by April 10, 2026, to claim credit and print your certificate. Claim now: https://ow.ly/HGGO50XKxJy
#HemeSky #MedSky #Hematology #HemeOnc
#HemeSky #MedSky #Hematology #HemeOnc
I assume they live in #SiliconValley but do they ever stir out? There are many parts of this country with no GPS access.
I remember as #medstudent going to #hemeonc preceptor #rural clinic in #Iowa - no bars on cell; planned route on paper, lonely country roads- never got lost - as a brown woman 🤯
I remember as #medstudent going to #hemeonc preceptor #rural clinic in #Iowa - no bars on cell; planned route on paper, lonely country roads- never got lost - as a brown woman 🤯
December 15, 2025 at 5:22 PM
I assume they live in #SiliconValley but do they ever stir out? There are many parts of this country with no GPS access.
I remember as #medstudent going to #hemeonc preceptor #rural clinic in #Iowa - no bars on cell; planned route on paper, lonely country roads- never got lost - as a brown woman 🤯
I remember as #medstudent going to #hemeonc preceptor #rural clinic in #Iowa - no bars on cell; planned route on paper, lonely country roads- never got lost - as a brown woman 🤯
Watch ASH News TV for in depth coverage from #ASH25 See the science, hear from leaders, and follow the updates unfolding live. Watch now: https://ow.ly/LEK050XF7yW #Hematology #HemeOnc
December 7, 2025 at 6:27 PM
Watch ASH News TV for in depth coverage from #ASH25 See the science, hear from leaders, and follow the updates unfolding live. Watch now: https://ow.ly/LEK050XF7yW #Hematology #HemeOnc
New studies at #ASH25 highlight a shift toward targeted therapies and immunotherapies for blood cancers, showing strong responses with less toxicity compared with traditional chemotherapy. Read for more: https://ow.ly/KR0z50XF6zS
#Hematology #HemeOnc
#Hematology #HemeOnc
December 7, 2025 at 3:10 PM
New studies at #ASH25 highlight a shift toward targeted therapies and immunotherapies for blood cancers, showing strong responses with less toxicity compared with traditional chemotherapy. Read for more: https://ow.ly/KR0z50XF6zS
#Hematology #HemeOnc
#Hematology #HemeOnc
A little behind the scenes at #ASH25 because so much heart goes into bringing this meeting to life. #ASHkudos to the crew behind the build and to the amazing attendees who make this meeting feel alive.
#Hematology #HemeOnc
#Hematology #HemeOnc
December 4, 2025 at 11:45 PM
A little behind the scenes at #ASH25 because so much heart goes into bringing this meeting to life. #ASHkudos to the crew behind the build and to the amazing attendees who make this meeting feel alive.
#Hematology #HemeOnc
#Hematology #HemeOnc
ASH is on its way to #ASH25!! ✈️
📸 Snap a photo of your journey to the meeting and check off this #ASHScavengerHunt item!
Safe travels to Orlando, everyone!
#Hematology #Hemeonc #HemeSky #MedSky
📸 Snap a photo of your journey to the meeting and check off this #ASHScavengerHunt item!
Safe travels to Orlando, everyone!
#Hematology #Hemeonc #HemeSky #MedSky
December 3, 2025 at 6:01 PM
ASH is on its way to #ASH25!! ✈️
📸 Snap a photo of your journey to the meeting and check off this #ASHScavengerHunt item!
Safe travels to Orlando, everyone!
#Hematology #Hemeonc #HemeSky #MedSky
📸 Snap a photo of your journey to the meeting and check off this #ASHScavengerHunt item!
Safe travels to Orlando, everyone!
#Hematology #Hemeonc #HemeSky #MedSky
Older adults with AML require tailored care. ASH’s new guideline provides clear, evidence-based recommendations for treating newly diagnosed patients and supporting decision-making in clinical practice.
Learn more: https://ow.ly/a0l850XAeAE
#HemeOnc #HemeSky #Leusm
Learn more: https://ow.ly/a0l850XAeAE
#HemeOnc #HemeSky #Leusm
December 1, 2025 at 7:11 PM
Older adults with AML require tailored care. ASH’s new guideline provides clear, evidence-based recommendations for treating newly diagnosed patients and supporting decision-making in clinical practice.
Learn more: https://ow.ly/a0l850XAeAE
#HemeOnc #HemeSky #Leusm
Learn more: https://ow.ly/a0l850XAeAE
#HemeOnc #HemeSky #Leusm
In my case I only managed to get back on my proper regimen because my hemeonc has enough pull to've gotten me in with the right clinic. Before my cancer doc basically said "hey he fucking needs this" I was getting snubbed left and right for even having had opioid use in my history at all
November 11, 2025 at 10:14 AM
In my case I only managed to get back on my proper regimen because my hemeonc has enough pull to've gotten me in with the right clinic. Before my cancer doc basically said "hey he fucking needs this" I was getting snubbed left and right for even having had opioid use in my history at all
📢 FINAL CALL! Don't miss your chance to apply for ASH CHAMP—a year-long opportunity to be paired with an expert mentor in classical hematology.
🔗https://ow.ly/fLYQ50Xjb19
#HemeSky #HemeOnc #MedSky
🔗https://ow.ly/fLYQ50Xjb19
#HemeSky #HemeOnc #MedSky
November 4, 2025 at 12:45 PM
📢 FINAL CALL! Don't miss your chance to apply for ASH CHAMP—a year-long opportunity to be paired with an expert mentor in classical hematology.
🔗https://ow.ly/fLYQ50Xjb19
#HemeSky #HemeOnc #MedSky
🔗https://ow.ly/fLYQ50Xjb19
#HemeSky #HemeOnc #MedSky
The Blood Health Information Hub is here! 🩸 This new ASH resource aims to counter misinformation and misconceptions by offering accurate, credible and trustworthy information on blood disorders. Read the first six topics: https://ow.ly/ATKM50Xkos0
#HemeSky #MedSky #HemeOnc
#HemeSky #MedSky #HemeOnc
October 30, 2025 at 5:01 PM
The Blood Health Information Hub is here! 🩸 This new ASH resource aims to counter misinformation and misconceptions by offering accurate, credible and trustworthy information on blood disorders. Read the first six topics: https://ow.ly/ATKM50Xkos0
#HemeSky #MedSky #HemeOnc
#HemeSky #MedSky #HemeOnc
Looking for your ideal candidate? Post your role to the ASH Job Center now!
>>> https://ow.ly/bvek50XfKKK
With #ASH25 around the corner, the ASH Job Center experiences its highest traffic of the year!
#Hematologyjobs #Healthcarejobs #Hematology #HemeOnc
>>> https://ow.ly/bvek50XfKKK
With #ASH25 around the corner, the ASH Job Center experiences its highest traffic of the year!
#Hematologyjobs #Healthcarejobs #Hematology #HemeOnc
October 25, 2025 at 6:00 PM
Looking for your ideal candidate? Post your role to the ASH Job Center now!
>>> https://ow.ly/bvek50XfKKK
With #ASH25 around the corner, the ASH Job Center experiences its highest traffic of the year!
#Hematologyjobs #Healthcarejobs #Hematology #HemeOnc
>>> https://ow.ly/bvek50XfKKK
With #ASH25 around the corner, the ASH Job Center experiences its highest traffic of the year!
#Hematologyjobs #Healthcarejobs #Hematology #HemeOnc
Connect, learn, grow! CHAMP pairs early-career fellows with mentors for clinical, research & career guidance. Virtual & in-person sessions support growth. Apply by Nov 6: https://ow.ly/RzJi50X9ix0
#ASHTrainee #ClassicalHeme #HemeOnc #Hematology #MedSky #HemeSky
#ASHTrainee #ClassicalHeme #HemeOnc #Hematology #MedSky #HemeSky
October 11, 2025 at 2:01 PM
Connect, learn, grow! CHAMP pairs early-career fellows with mentors for clinical, research & career guidance. Virtual & in-person sessions support growth. Apply by Nov 6: https://ow.ly/RzJi50X9ix0
#ASHTrainee #ClassicalHeme #HemeOnc #Hematology #MedSky #HemeSky
#ASHTrainee #ClassicalHeme #HemeOnc #Hematology #MedSky #HemeSky
Patients who received #cyclosporin and #cyclophosphamide for #GVHD prevention after #HCT had improved outcomes compared to those receiving the standard cyclosporin and #methotrexate, with a median GRFS of 26.2 months vs. 6.4 months: ow.ly/pOA250WXckE #HemeSky #HemeOnc
Cyclosporin-Cyclophosphamide Performs Well for GVHD Prevention After Transplant | ASH Clinical News | American Society of Hematology
ow.ly
October 3, 2025 at 8:06 PM
Patients who received #cyclosporin and #cyclophosphamide for #GVHD prevention after #HCT had improved outcomes compared to those receiving the standard cyclosporin and #methotrexate, with a median GRFS of 26.2 months vs. 6.4 months: ow.ly/pOA250WXckE #HemeSky #HemeOnc
Rohan, who has acute myeloid leukemia, says he’s alive today because of federally funded research. His story is a powerful reminder: Research saves lives. Learn more: https://ow.ly/xH3q50X4EOI
#Fight4Hematology #ResearchSavesLives #Leusm #HemeOnc
#Fight4Hematology #ResearchSavesLives #Leusm #HemeOnc
October 3, 2025 at 1:02 PM
Rohan, who has acute myeloid leukemia, says he’s alive today because of federally funded research. His story is a powerful reminder: Research saves lives. Learn more: https://ow.ly/xH3q50X4EOI
#Fight4Hematology #ResearchSavesLives #Leusm #HemeOnc
#Fight4Hematology #ResearchSavesLives #Leusm #HemeOnc
Explore the benefits and risks of aggressive vs. non-aggressive MCL treatment strategies in our expert-led session, Fri. Oct. 3. Secure your spot today. #HemeSky #HemeOnc bit.ly/4nWEIli
September 30, 2025 at 5:39 PM
Explore the benefits and risks of aggressive vs. non-aggressive MCL treatment strategies in our expert-led session, Fri. Oct. 3. Secure your spot today. #HemeSky #HemeOnc bit.ly/4nWEIli